Emodin modulates gut microbial community and triggers intestinal immunity

Area of Science:

• Microbiology
• Immunology
• Pharmacology

Background:

• The gut microbiota (GM) is crucial for human health and a therapeutic target.
• Emodin's effects on GM are largely unexplored, despite its known health benefits.
• This study investigates emodin's impact on the gut microbiota in vitro and in vivo.

Purpose of the Study:

• To determine the effects of emodin on gut microbial composition.
• To assess emodin's influence on host immune responses.
• To explore emodin as a potential modulator of the gut microbiota for health improvement.

Main Methods:

• In vitro cultivation of single bacteria and co-culture models.
• Analysis of microbial community structure.
• In vivo experiments in mice to evaluate GM and immune responses.

Main Results:

• Emodin selectively stimulated beneficial bacteria (Akkermansia, Clostridium, Roseburia, Ruminococcus) while inhibiting major enterotypes (Bacteroides, Prevotella).
• Consistent GM modulation by emodin was observed across monoculture, co-culture, and in vivo models.
• Emodin stimulated specific gut bacteria in mice, correlating with induced anti-inflammatory regulatory T-cell immune responses.

Conclusions:

• Emodin consistently altered the gut microbiota across different experimental models.
• Emodin stimulated regulatory T-cell immune responses in vivo.
• Emodin shows potential for modulating the gut microbiota and improving host health.